Related Experiment Videos

Prophylactic trimethoprim for prostatectomy

Urology
|October 1, 1984
PubMed

Insights

Single-dose trimethoprim prophylaxis did not significantly reduce infection rates in prostatectomy patients. Further research is needed to establish the efficacy of antimicrobial prophylaxis for this surgical procedure.

Area of Science:

  • Urology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Prostatectomy is a common surgical procedure.
  • Post-operative infections are a potential complication.
  • Antimicrobial prophylaxis is often used to prevent infections.

Purpose of the Study:

  • To evaluate the efficacy of a single dose of trimethoprim for infection prophylaxis in prostatectomy patients.
  • To compare outcomes between transurethral and abdominal prostatectomy approaches.

Main Methods:

  • A double-blind, placebo-controlled clinical trial.
  • 260 prostatectomy patients were enrolled.
  • Patients received either 300 mg trimethoprim or a placebo.

Main Results:

  • Trimethoprim did not prevent intraoperative bacteremia.
  • No significant difference in infection rates was observed between the trimethoprim and placebo groups for either surgical approach.
  • Risk factors for infection did not differ significantly between groups.

Conclusions:

  • The efficacy of antimicrobial prophylaxis in prostatectomy remains unproven.
  • The effectiveness may be too low for general recommendation.
  • Further studies are warranted to determine optimal prophylactic strategies.

Related Concept Videos